For biopharma, reaching the right patients at the right time is essential for both clinical and commercial success. The right ...
The potential approval of Vertex’s IgAN therapy povetacicept in 2026 comes amid launch headwinds for the company’s non-opioid ...
The Dr. Azfar Malik Grant for Healthcare Students is now accepting applications for its annual scholarship program. The grant ...
One recent morning, tutor Saul Escorza, a recent University of Pennsylvania graduate, sat at a high-top table on the school’s ...
Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® ...
The MLA for Steinbach calls it shocking that a local family has not heard back from the Health Minister regarding their dying ...
Rapid patient enrollment underscores strong market interest and reinforces commercialization opportunity for fully implanted ...
Once-daily, effective, safe, and well-tolerated ZORYVE cream 0.05% now commercially available for children as young as age 2ZORYVE cream 0.05% ...
A Cheyenne clinic has just added a remote blood-pressure monitoring program for high-risk pregnancies. It’s just the latest ...
5d
Apellis Pharmaceuticals, Inc.: Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results
Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® (pegcetacoplan) in the first two months since launch in ...
Coherix is expanding its production and product development facilities to meet a growing demand for AI-based quality-control systems to control the application of adhesives in the assembly of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback